Huber Capital Management LLC Abb Vie Inc. Transaction History

Huber Capital Management LLC

$476 Million
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$107.43 - $135.93 $618,689 - $782,820	-5,759 Reduced 93.51%	400 $54,000
Q3 2021 Nov 12, 2021	SELL	$106.4 - $120.78 $95,760 - $108,702	-900 Reduced 12.75%	6,159 $664,000
Q2 2021 Aug 13, 2021	SELL	$105.21 - $117.21 $52,605 - $58,605	-500 Reduced 6.61%	7,059 $795,000
Q1 2021 May 14, 2021	SELL	$102.3 - $112.62 $511,500 - $563,100	-5,000 Reduced 39.81%	7,559 $818,000
Q4 2020 Feb 12, 2021	BUY	$80.49 - $108.67 $32,195 - $43,468	400 Added 3.29%	12,559 $1.35 Million
Q3 2020 Nov 13, 2020	SELL	$85.91 - $100.83 $647,160 - $759,552	-7,533 Reduced 38.25%	12,159 $1.07 Million
Q2 2020 Aug 13, 2020	SELL	$73.37 - $98.18 $2.62 Million - $3.5 Million	-35,645 Reduced 64.41%	19,692 $1.93 Million
Q1 2020 May 14, 2020	BUY	$64.5 - $97.79 $96,750 - $146,685	1,500 Added 2.79%	55,337 $4.22 Million
Q4 2019 Feb 13, 2020	SELL	$72.13 - $90.25 $72,130 - $90,250	-1,000 Reduced 1.82%	53,837 $4.77 Million
Q3 2019 Nov 13, 2019	BUY	$62.98 - $75.72 $1.92 Million - $2.31 Million	30,500 Added 125.32%	54,837 $4.15 Million
Q2 2019 Aug 13, 2019	BUY	$65.7 - $83.98 $657,000 - $839,800	10,000 Added 69.75%	24,337 $1.77 Million
Q1 2019 May 14, 2019	SELL	$77.14 - $90.79 $1.23 Million - $1.44 Million	-15,900 Reduced 52.58%	14,337 $1.16 Million
Q3 2018 Nov 13, 2018	BUY	$88.91 - $98.84 $1.42 Million - $1.58 Million	16,000 Added 112.38%	30,237 $2.86 Million
Q1 2018 May 14, 2018	SELL	$92.01 - $123.21 $92,010 - $123,210	-1,000 Reduced 6.56%	14,237 $1.35 Million
Q3 2017 Nov 13, 2017	BUY	$69.85 - $89.22 $1.06 Million - $1.36 Million	15,237	15,237 $1.35 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Huber Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Huber Capital Management LLC with notifications on news.

Account